Effect of praziquantel and oxamniquine treatment on human isotype responses to Schistosoma mansoni: elevated IgE to adult worm

article

Effect of praziquantel and oxamniquine treatment on human isotype responses to Schistosoma mansoni: elevated IgE to adult worm is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1046/J.1365-3024.1997.D01-211.X
P698PubMed publication ID9278946

P50authorDavid W DunneQ30513910
Padraic G. FallonQ42944857
P2093author name stringM Webster
J H Ouma
A E Butterworth
G Kimani
A J Fulford
P433issue7
P921main subjectpraziquantelQ424145
oxamniquineQ682497
Schistosoma mansoniQ2324689
P304page(s)333-335
P577publication date1997-07-01
P1433published inParasite ImmunologyQ15751559
P1476titleEffect of praziquantel and oxamniquine treatment on human isotype responses to Schistosoma mansoni: elevated IgE to adult worm
P478volume19

Reverse relations

cites work (P2860)
Q34038437Analysis of the effects of treatment of human Schistosoma mansoni infection on the immune response of patients from endemic areas
Q44021869Antibody isotype responses to Schistosoma japonicum antigens in subjects from a schistosomiasis area with repeated praziquantel chemotherapy compared with a new endemic zone in Hunan Province, P.R. China
Q39177940Antibody isotype responses, infection and re-infection for Schistosoma japonicum in a marshland area of China
Q35088439Association of Schistosoma mansoni-specific IgG and IgE antibody production and clinical schistosomiasis status in a rural area of Minas Gerais, Brazil
Q62486477Benefits of annual chemotherapeutic control of schistosomiasis on the development of protective immunity
Q34760480Chemotherapy for schistosomiasis in Ugandan fishermen: treatment can cause a rapid increase in interleukin-5 levels in plasma but decreased levels of eosinophilia and worm-specific immunoglobulin E
Q44091869Down-regulation of specific antigen-driven cytokine production in a population with endemic Schistosoma japonicum infection
Q53697118Effect of four rounds of annual school-wide mass praziquantel treatment for schistosoma mansoni control on schistosome-specific immune responses.
Q36506153Effects of treatment on IgE responses against parasite allergen-like proteins and immunity to reinfection in childhood schistosome and hookworm coinfections
Q34601522Eosinophil activity in Schistosoma mansoni infections in vivo and in vitro in relation to plasma cytokine profile pre- and posttreatment with praziquantel
Q38887560Hepatosplenic schistosomiasis: playing hide-and-seek with an elusive parasite
Q43901475Heterogeneities in anti-schistosome humoral responses following chemotherapy
Q45243644Human IgE response to the Schistosoma haematobium 22.6 kDa antigen.
Q38887383Human IgE responses to rSm22.6 are associated with infection intensity rather than age per se, in a recently established focus of Schistomiasis mansoni
Q33245126Human antibody responses of patients living in endemic areas for schistosomiasis to the tegumental protein Sm29 identified through genomic studies.
Q33965354Increases in levels of schistosome-specific immunoglobulin E and CD23(+) B cells in a cohort of Kenyan children undergoing repeated treatment and reinfection with Schistosoma mansoni
Q21092289Influence of exposure history on the immunology and development of resistance to human Schistosomiasis mansoni
Q37994231Parasite glycans and antibody-mediated immune responses in Schistosoma infection
Q24646962Pilot-scale production and characterization of paramyosin, a vaccine candidate for schistosomiasis japonica
Q31920496Role of adult worm antigen-specific immunoglobulin E in acquired immunity to Schistosoma mansoni infection in baboons
Q40279125Schistosome immunology: more questions than answers
Q35938440Similar cellular responses after treatment with either praziquantel or oxamniquine in Schistosoma mansoni infection
Q28547483Single Versus Double Dose Praziquantel Comparison on Efficacy and Schistosoma mansoni Re-Infection in Preschool-Age Children in Uganda: A Randomized Controlled Trial
Q43756314The impact of repeated treatment with praziquantel of schistosomiasis in children under six years of age living in an endemic area for Schistosoma haematobium infection

Search more.